On November 3, CHINA LIFE recorded an Intraday Rise of 3.06% in Regular Trading, trading at HK$25.56 with turnover of HK$1.061 billion.
The move aligns with strength across Hong Kong-listed insurers after sector commentary said insurance stocks may see a valuation rebound once market expectations stabilize, as current valuations remain low despite near-term concerns over asset-side volatility.
Company-specific developments also offered support. CHINA LIFE’s latest quarterly report showed first nine-month premium income of RMB676.14 billion, up 1.0%, while new business value rose 13.1%, described by multiple broker notes as leading peers. Core solvency adequacy stayed solid at 156.29%, and several brokers maintained buy or overweight-equivalent views even after a third-quarter loss tied mainly to market fluctuations. Recent disclosure filings also showed stake increases by major institutions including FMR LLC and BlackRock.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments